An inevitable question faced by primary care physicians managing patients with type 2 diabetes mellitus is: “How should treatment be intensified when the combination of lifestyle management and metformin does not provide the desired glycemic control?” While many options are available, there is no single answer to this question. This supplement discusses the benefits and limitations of the options for lowering blood glucose, with emphasis on the glucagon-like peptide-1 receptor agonists and insulin. Designed to provide a practical discussion of individualizing treatment and promoting patient self-management, tips are included to improve physician-patient communication and case studies are presented to reinforce key concepts.
Medical Education Library
Intensifying type 2 diabetes therapy: Assessing the options
This supplement was sponsored by Primary Care Metabolic Group and PCEC and is supported by funding from Novo Nordisk Inc.
